Drug Commercialization
list 4 séquences
assignment Niveau : Introductif
chat_bubble_outline Langue : Anglais
card_giftcard 7.2 points
Envie de partager ce MOOC dans votre entreprise ?
My Mooc
For Business
4.5 /5
Avis de la communauté
6 avis

Les infos clés

credit_card Formation gratuite
verified_user Certification payante
timer 12 heures de cours

En résumé

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environ­ment using a much larger group of patients. This enables new treat­ment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall develop­ment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.

more_horiz Lire plus
more_horiz Lire moins
dns

Le programme

  • Week 1 - Welcome!
     
  • Week 1 - Pharmacoeconomics in Drug Development, Jan Hirsch, Ph.D.
     
  • Week 1 - Intellectual Property Strategy & BioSimilars, Williams Ettouati, Pharm.D.
     
  • Week 2 - Marketing Pharmaceuticals & Biotechnology Drugs, Williams Ettouati, Pharm.D.
     
  • Week 2 - Managed Markets and Sales Strategy, Doral Fredericks, Pharm.D., MBA
     
  • Week 3 - Strategic Alliances in Academia, Pharma and Biotech, Williams Ettouati, Pharm. D.
     
  • Week 3 - Business Models and Portfolio Management
     
  • Week 4 - Academic Industry partnership "Various models, Various outcomes", Remi Brouard, M.D.
     
  • Week 4 - From Start up to Success in Biotech, Barry Quart, Pharm.D.
     
record_voice_over

Les intervenants

Williams S. Ettouati, Pharm.D., Director, Industrial Relations & Development; Health Sciences Associate Clinical Professor, N.S.

  • Skaggs School of Pharmacy and Pharmaceutical Sciences

Joseph D. Ma, Associate Professor of Clinical Pharmacy

  • Skaggs School of Pharmacy and Pharmaceutical Sciences
store

Le concepteur

UC San Diego is an academic powerhouse and economic engine, recognized as one of the top 10 public universities by U.S. News and World Report. Innovation is central to who we are and what we do. Here, students learn that knowledge isn't just acquired in the classroom—life is their laboratory.
assistant

La plateforme

Coursera est une entreprise numérique proposant des formation en ligne ouverte à tous fondée par les professeurs d'informatique Andrew Ng et Daphne Koller de l'université Stanford, située à Mountain View, Californie.

Ce qui la différencie le plus des autres plateformes MOOC, c'est qu'elle travaille qu'avec les meilleures universités et organisations mondiales et diffuse leurs contenus sur le web.

Avis de la communauté
4.5 /5 Moyenne
4
1
1
0
0
Contenu
4.5/5
Plateforme
4.5/5
Animation
4.5/5
Le meilleur avis

It was really helpful as a peson with a backgound on biochemistry but so little knowledge in the commercial side of pharma. Definitely recommended.

le 27 août 2017
Vous êtes le concepteur de ce MOOC ?
Quelle note donnez-vous à cette ressource ?
Contenu
0/5
Plateforme
0/5
Animation
0/5
le 12 septembre 2017

Interesting course with some interesting and relevant case studies. This is a great 101 course with stronger focus in certain areas of commercialization.

le 27 août 2017

It was really helpful as a peson with a backgound on biochemistry but so little knowledge in the commercial side of pharma. Definitely recommended.

le 24 août 2017

Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.

le 10 février 2017

This is yet another brilliant module by Dr. Ettouati and Dr. Ma. I really appreciate their bringing in industry experts with deep expertise, practical experience and insights to make this an engaging and interesting course. Definitely recommend it to anyone looking to get a good overview of the Drug commercialization process.

le 8 janvier 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.